Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Explain your process for handling and documenting deviations from established procedures.

Posted on August 10, 2023August 10, 2023 By digi

Auditee: Our process for handling and documenting deviations from established procedures is a critical aspect of maintaining compliance, product quality, and continuous improvement. Deviations, whether minor or major, are thoroughly addressed to identify root causes, implement corrective actions, and prevent recurrence.

Deviation Identification: Deviations can arise from various sources, including equipment malfunctions, human error, unexpected events, or process variations. Our process begins with the prompt identification of deviations through vigilant monitoring, inspections, and quality control checks.

Immediate Response: Upon identifying a deviation, our team takes immediate actions to mitigate its impact. This may include pausing operations, segregating affected materials, or implementing temporary

measures to ensure product quality and patient safety.

Also Read:  The Impact of GMP on Pharmaceutical Supply Chain Risk Management

Deviation Documentation: Deviations are documented in detail to provide a comprehensive record of the event. The documentation includes:

  • Description: A clear and concise description of the deviation, including when and where it occurred, the affected process or area, and any relevant context.
  • Impact Assessment: An assessment of the potential impact on product quality, patient safety, and regulatory compliance.
  • Root Cause Analysis: A thorough investigation into the root causes of the deviation. This involves identifying contributing factors, process weaknesses, and any systemic issues.
  • Corrective Actions: Well-defined corrective actions are formulated based on the root cause analysis. These actions are designed to address the immediate concern, prevent recurrence, and strengthen the overall process.
  • Preventive Actions: To prevent similar deviations in the future, preventive actions are established. These actions target the underlying causes, ensuring long-term process improvement.
  • Implementation Plan: A detailed plan outlines how each corrective and preventive action will be implemented, who is responsible, and the expected completion date.
  • Verification and Effectiveness: The effectiveness of the actions taken is verified through testing, validation, or other appropriate methods. This step ensures that the deviation has been successfully addressed.
  • Approval and Sign-Off: Deviation documentation is reviewed, approved, and signed off by relevant personnel, including quality assurance, regulatory affairs, and operations.
Also Read:  Walk us through your process for handling and documenting employee training records.

Record Retention: Deviation documentation is retained as part of our quality records. These records serve as valuable references for audits, inspections, and continuous improvement efforts.

By rigorously following our deviation handling process, we demonstrate our commitment to maintaining compliance, ensuring product quality, and fostering a culture of continuous improvement within our organization.

US FDA Mock Audits Tags:Audit process, Batch Record Review and Approval in GMP, Benefits of GMP Implementation, Cleaning and Sanitation in GMP Facilities, Compliance documentation, Contamination Prevention, Corrective actions, Deviations and Non-Conformities in GMP, Documentation Requirements in GMP, Equipment Calibration and Maintenance in GMP, GMP, GMP Enforcement and Monitoring, GMP guidelines, GMP Regulations, Good Manufacturing Practices (GMP), Inspection procedures, Internal audits, Manufacturing validation, Non-Compliance Consequences, Personnel Training in GMP, Pharmaceutical Industry, Preventive measures, Process Validation in GMP, Product Quality and Safety, Product quality assurance, Quality Control (QC) in GMP Compliance, Quality control procedures, Quality management system, Raw Materials Control in GMP, Regulatory communication, Regulatory compliance, Risk assessment, Specifications and Acceptance Criteria under GMP, Stability Studies in GMP, Storage and Distribution of Pharmaceutical Products under GMP, US FDA Audit

Post navigation

Previous Post: Provide examples of risk assessments you’ve conducted on your processes, products, and suppliers.
Next Post: Show us your facility’s organization, cleanliness, and measures for preventing cross-contamination.

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Never Handle Rejected Goods During Active GMP Production

    Never Handle Rejected Goods During… Read more

Mock Audits

  • US FDA Mock Audits

US FDA Mock Audits

  • Can you provide an overview of your quality management system (QMS) and how it ensures compliance with FDA regulations?
  • How are employees trained on FDA regulations and guidelines relevant to their roles?
  • Can you demonstrate how your documentation practices ensure accuracy, traceability, and completeness?
  • How do you maintain and calibrate critical equipment used in your manufacturing process?
  • Show us your facility’s organization, cleanliness, and measures for preventing cross-contamination.
  • Explain your process for handling and documenting deviations from established procedures.
  • Provide examples of risk assessments you’ve conducted on your processes, products, and suppliers.
  • How do you manage and document changes to processes, equipment, or materials?
  • Walk us through your procedure for investigating and addressing customer complaints related to product quality.
  • Can you show us how you handle and document product recalls, if necessary?

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme